GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] proposal — a flair for co-agonism posts — 52 comments in the full submission. View in context.
2.3k
c/cagrilintide·submitted 6 months ago by u/lukas_vermeulen

[Meta] proposal — a flair for co-agonism posts

Labbranch of 5 comments

Been lurking in c/orforglipron for about 14 months and finally have something worth posting. Short version: week 88, 10mg, and amylin is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 27 threads, and the answers split roughly down the middle. What I actually want to know…

Read the full submission and all 52 comments →

This branch

5 comments, started 6 months ago
u/ferritin_low297 points·6 months ago

long-acting amylin is co-agonism, different satiety profile

replysharereportpermalink
u/nadia_bakker-24 points·6 months ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/lukas_vermeulenOP1 point·6 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/ravi_sandvik1 point·6 months ago

not approved anywhere, keep posts descriptive, not instructional

replysharereportpermalink
[deleted]1 point·6 months ago

[deleted]

replysharereportpermalink

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.